PortfoliosLab logoPortfoliosLab logo
SGRY vs. EHC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SGRY vs. EHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Surgery Partners, Inc. (SGRY) and Encompass Health Corporation (EHC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SGRY achieves a -5.95% return, which is significantly lower than EHC's -5.52% return.


SGRY

1D
-0.14%
1M
8.43%
YTD
-5.95%
6M
-6.44%
1Y
-28.07%
3Y*
-28.92%
5Y*
-26.29%
10Y*
-1.06%

EHC

1D
1.24%
1M
-4.82%
YTD
-5.52%
6M
-6.49%
1Y
-16.35%
3Y*
16.23%
5Y*
10.55%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SGRY vs. EHC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SGRY
Surgery Partners, Inc.
-5.95%-27.02%-33.82%14.82%-47.84%84.11%85.31%59.91%-19.09%-0.82%
EHC
Encompass Health Corporation
-5.52%15.67%39.17%12.62%16.77%-19.90%21.42%14.26%26.89%0.20%

Correlation

The correlation between SGRY and EHC is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.38

Correlation (5Y)
Calculated over the trailing 5-year period

0.45

Correlation (All Time)
Calculated using the full available price history since Dec 29, 2017

0.44

Over the past year, the correlation between SGRY and EHC has dropped to 0.22 - well below their long-term average of 0.44, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

SGRY:

$1.87B

EHC:

$10.05B

EPS

SGRY:

-$0.60

EHC:

$5.99

PS Ratio

SGRY:

0.55

EHC:

1.68

PB Ratio

SGRY:

1.10

EHC:

3.04

Total Revenue (TTM)

SGRY:

$3.34B

EHC:

$6.07B

Gross Profit (TTM)

SGRY:

$763.30M

EHC:

$2.44B

EBITDA (TTM)

SGRY:

$787.20M

EHC:

$1.42B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SGRY vs. EHC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGRY
SGRY Risk / Return Rank: 2020
Overall Rank
SGRY Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
SGRY Sortino Ratio Rank: 1919
Sortino Ratio Rank
SGRY Omega Ratio Rank: 1717
Omega Ratio Rank
SGRY Calmar Ratio Rank: 2323
Calmar Ratio Rank
SGRY Martin Ratio Rank: 2424
Martin Ratio Rank

EHC
EHC Risk / Return Rank: 1717
Overall Rank
EHC Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
EHC Sortino Ratio Rank: 1616
Sortino Ratio Rank
EHC Omega Ratio Rank: 1616
Omega Ratio Rank
EHC Calmar Ratio Rank: 1919
Calmar Ratio Rank
EHC Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SGRY vs. EHC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Surgery Partners, Inc. (SGRY) and Encompass Health Corporation (EHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SGRYEHCDifference
Sharpe ratioReturn per unit of total volatility

-0.02

Sortino ratioReturn per unit of downside risk

+0.14

Omega ratioGain probability vs. loss probability

0.91

0.90

+0.01

Calmar ratioReturn relative to maximum drawdown

-0.54

-0.63

+0.09

Martin ratioReturn relative to average drawdown

-0.91

-1.15

+0.24

SGRY vs. EHC - Sharpe Ratio Comparison

The current SGRY Sharpe Ratio is -0.62, which is comparable to the EHC Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of SGRY and EHC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SGRY vs. EHC - Drawdown Comparison

The maximum SGRY drawdown since its inception was -82.86%, which is greater than EHC's maximum drawdown of -39.54%. Use the drawdown chart below to compare losses from any high point for SGRY and EHC.


Loading charts...

Drawdown Indicators


SGRYEHCDifference

Max Drawdown

Largest peak-to-trough decline

-82.86%

-39.54%

-43.32%

Max Drawdown (1Y)

Largest decline over 1 year

-51.80%

-26.09%

-25.71%

Max Drawdown (3Y)

Largest decline over 3 years

-74.52%

-26.09%

-48.43%

Max Drawdown (5Y)

Largest decline over 5 years

-82.86%

-35.10%

-47.76%

Max Drawdown (10Y)

Largest decline over 10 years

-82.86%

Current Drawdown

Current decline from peak

-78.33%

-21.15%

-57.18%

Average Drawdown

Average peak-to-trough decline

-41.71%

-12.13%

-29.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.05%

14.29%

+16.76%

Volatility

SGRY vs. EHC - Volatility Comparison

Surgery Partners, Inc. (SGRY) has a higher volatility of 10.62% compared to Encompass Health Corporation (EHC) at 8.64%. This indicates that SGRY's price experiences larger fluctuations and is considered to be riskier than EHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SGRYEHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.62%

8.64%

+1.98%

Volatility (6M)

Calculated over the trailing 6-month period

28.97%

20.87%

+8.10%

Volatility (1Y)

Calculated over the trailing 1-year period

45.51%

27.21%

+18.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.68%

26.08%

+28.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.76%

28.28%

+36.48%

Dividends

SGRY vs. EHC - Dividend Comparison

SGRY has not paid dividends to shareholders, while EHC's dividend yield for the trailing twelve months is around 0.74%.


PositionTTM202520242023202220212020201920182017
EHC
Encompass Health Corporation
0.74%0.66%0.51%0.90%20.45%1.72%1.35%1.59%1.69%0.51%
SGRY
Surgery Partners, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SGRY vs. EHC - Financials Comparison

This section allows you to compare key financial metrics between Surgery Partners, Inc. and Encompass Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M800.00M1.00B1.20B1.40B1.60B20222023202420252026
810.90M
1.59B
(SGRY) Total Revenue
(EHC) Total Revenue
Values in USD except per share items

SGRY vs. EHC - Profitability Comparison

The chart below illustrates the profitability comparison between Surgery Partners, Inc. and Encompass Health Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
19.8%
48.4%
Portfolio components
SGRY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported a gross profit of 160.20M and revenue of 810.90M. Therefore, the gross margin over that period was 19.8%.

EHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Encompass Health Corporation reported a gross profit of 768.50M and revenue of 1.59B. Therefore, the gross margin over that period was 48.4%.

SGRY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported an operating income of 65.80M and revenue of 810.90M, resulting in an operating margin of 8.1%.

EHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Encompass Health Corporation reported an operating income of 232.30M and revenue of 1.59B, resulting in an operating margin of 14.6%.

SGRY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported a net income of -35.90M and revenue of 810.90M, resulting in a net margin of -4.4%.

EHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Encompass Health Corporation reported a net income of 194.50M and revenue of 1.59B, resulting in a net margin of 12.3%.


Frequently Asked Questions


SGRY and EHC have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SGRY has higher volatility (10.62%) compared to EHC (8.64%). In terms of maximum drawdown, SGRY dropped -82.86% vs EHC's -39.54%.

EHC currently has the higher Sharpe Ratio (-0.60 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SGRY and EHC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer